| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |